Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keizo Yoshida

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Neuropsychobiology|November 13, 2004
Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a japanese populationKazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, et al.
Psychiatry and Clinical Neurosciences|December 18, 2007
Age of onset has limited association with body mass index at time of presentation for anorexia nervosa: comparison of peak-onset and late-onset anorexia nervosa groupsHiroyuki Kimura, Takashi Tonoike, Tamio Muroya, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 3, 2004
Effect of quetiapine in the treatment of panic attacks in patients with schizophrenia: 3 case reportsHitoshi Takahashi, Takio Sugita, Keizo Yoshida, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 10, 2009
[Age of onset has limited association with body mass index at time of presentation for anorexia nervosa: comparison of peak-onset and late-onset anorexia nervosa groups]Hiroyuki Kimura, Takashi Tonoike, Tamio Muroya, et al.
Clinical Neuropharmacology|June 5, 2007
Successful treatment of trigeminal neuralgia with milnacipranMikiko Ito, Keizo Yoshida, Hiroyuki Kimura, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2005
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reportsHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
The Journal of Clinical Psychiatry|November 17, 2006
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trialHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Human Psychopharmacology|January 4, 2008
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case seriesHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case seriesHitoshi Takahashi, Keizo Yoshida, Takio Sugita, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Neuropsychobiology|November 13, 2004
Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a japanese populationKazuyuki Inoue, Kunihiko Itoh, Keizo Yoshida, et al.
Psychiatry and Clinical Neurosciences|December 18, 2007
Age of onset has limited association with body mass index at time of presentation for anorexia nervosa: comparison of peak-onset and late-onset anorexia nervosa groupsHiroyuki Kimura, Takashi Tonoike, Tamio Muroya, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|March 3, 2004
Effect of quetiapine in the treatment of panic attacks in patients with schizophrenia: 3 case reportsHitoshi Takahashi, Takio Sugita, Keizo Yoshida, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|November 10, 2009
[Age of onset has limited association with body mass index at time of presentation for anorexia nervosa: comparison of peak-onset and late-onset anorexia nervosa groups]Hiroyuki Kimura, Takashi Tonoike, Tamio Muroya, et al.
Clinical Neuropharmacology|June 5, 2007
Successful treatment of trigeminal neuralgia with milnacipranMikiko Ito, Keizo Yoshida, Hiroyuki Kimura, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2005
Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reportsHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
The Journal of Clinical Psychiatry|November 17, 2006
Switching to olanzapine after unsuccessful treatment with risperidone during the first episode of schizophrenia: an open-label trialHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Human Psychopharmacology|January 4, 2008
Augmentation with olanzapine in TCA-refractory depression with melancholic features: a consecutive case seriesHitoshi Takahashi, Mitsuhiro Kamata, Keizo Yoshida, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 15, 2003
Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case seriesHitoshi Takahashi, Keizo Yoshida, Takio Sugita, et al.
Clinical Neuropharmacology|October 2, 2003
Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reportsHitoshi Takahashi, Keizo Yoshida, Hisashi Higuchi, et al.
Pageof 7